Skip to content
All articles

Retrospective cohort study of subsequent primary cancer diagnosis among patients with neuroendocrine tumors

Dr. Udhayvir Grewal
Dr. Udhayvir Grewal

Neuroendocrine tumors (NETs) are heterogeneous malignant tumors with a rising incidence and are often associated with prolonged survival, making subsequent primary cancers (SPCs) an important consideration. A retrospective cohort study using the SEER database (2000-2021) evaluated the risk of SPCs among patients with a NET diagnosis. The analytic cohort included 95 625 patients with NET (52.87% female) of whom 20 119 (21.04%) had early-onset NETs (diagnosed before age 50 years). Over a median follow-up of 47 months, 7086 patients (7.41%) developed SPCs. SPCs occurred in 999 patients (4.97%) with early-onset NETs compared with 6087 patients (8.06%) with average-onset NETs. Early-onset NET was associated with a lower subdistribution hazard of SPC that attenued with increasing follow-up. Compared with average-onset NET, adjusted time-specific sHRs were 0.35 ((5% CI 0.30-0.41) at 1 year; 0.50 (0.46-0.54) at 3 years, 0.59 (0.55-0.63) at 5 years, and0.73 (0.67-0.80) at 10 years. Primary site distribution differed by age, with appendiceal NETs more common among younger than older patients, and lung/bronchus and small-intestinal NETs less common among patients younger than 50 years versus older patients. Within the early-onset cohort, male sex was associated with lower SPC risk (sHR 0.84; 95% CI 0.74-0.95). Gastric (sHR 2.60; 95% CI 2.14-3.17), pancreatic (1.47; 1,18-1.83), and small-intestinal (1.33; 1.09-1.63) NETs were associated with higher risk, and appendiceal NETs (0.73; 0.56-0.94) were associated with lower risk. The authors conclude that early-onset NETs were associated with significantly lower overall SPC hazards, with substantial heterogeneity in risk.

Original publicationjamanetwork.com
Read the publication